Melanie Rakita - Apr 3, 2023 Form 3 Insider Report for L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Role
Vice President & CHRO
Signature
By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Melanie Rakita
Stock symbol
LHX
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
3
Date filed
4/5/2023, 04:39 PM
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LHX Common Stock, Par Value $1.00 737 Apr 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LHX Non-Qualified Stock Option (Right to Buy) Apr 3, 2023 Common Stock, Par Value $1.00 1.81K $197.73 Direct F1
holding LHX Non-Qualified Stock Option (Right to Buy) Apr 3, 2023 Common Stock, Par Value $1.00 1.63K $181.91 Direct F2
holding LHX Non-Qualified Stock Option (Right to Buy) Apr 3, 2023 Common Stock, Par Value $1.00 1.27K $233.51 Direct F3
holding LHX Non-Qualified Stock Option (Right to Buy) Apr 3, 2023 Common Stock, Par Value $1.00 1.3K $210.15 Direct F4
holding LHX Restricted Stock Units Apr 3, 2023 Common Stock, Par Value $1.00 1.79K $0.00 Direct F5
holding LHX Restricted Stock Units Apr 3, 2023 Common Stock, Par Value $1.00 378 $0.00 Direct F5
holding LHX Restricted Stock Units Apr 3, 2023 Common Stock, Par Value $1.00 3K $0.00 Direct F6
holding LHX Restricted Stock Units Apr 3, 2023 Common Stock, Par Value $1.00 295 $0.00 Direct F5
holding LHX Restricted Stock Units Apr 3, 2023 Common Stock, Par Value $1.00 340 $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to purchase shares of Issuer's common stock, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.
F2 Options to purchase shares of Issuer's common stock, 543 of which became exercisable on 2/26/2022, 544 of which became exercisable on 2/26/2023 and 544 of which become exercisable on 2/26/2024, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.
F3 Options to purchase shares of Issuer's common stock, 424 of which became exercisable on 2/25/2023, 424 of which become exercisable on 2/25/2024 and 425 of which become exercisable on 2/25/2025, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.
F4 Options to purchase shares of Issuer's common stock, 433 of which become exercisable on 2/24/2024, 433 of which become exercisable on 2/24/2025 and 433 of which become exercisable on 2/24/2026, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.
F5 Award of restricted stock units, which vest subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to receive 1 share of common stock, with vested units settled in shares common stock.
F6 Award of restricted stock units, of which one-half vests on 2/1/2025 and one-half vests on 2/1/2026, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to 1 share of Issuer's common stock, with vested units settled in shares of Issuer's common stock.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney